B. U. Dayanc Et Al. , "Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen," JOURNAL OF THORACIC ONCOLOGY , no.9, 2022
Dayanc, B. U. Et Al. 2022. Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen. JOURNAL OF THORACIC ONCOLOGY , no.9 .
Dayanc, B. U., Eris, S., Cakiroglu, E., Mazi, F. A., COŞKUN BADUR, S., Demirci, D., ... KARAKÜLAH, G.(2022). Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen. JOURNAL OF THORACIC ONCOLOGY , no.9.
Dayanc, B. Et Al. "Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen," JOURNAL OF THORACIC ONCOLOGY , no.9, 2022
Dayanc, B. U. Et Al. "Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen." JOURNAL OF THORACIC ONCOLOGY , no.9, 2022
Dayanc, B. U. Et Al. (2022) . "Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen." JOURNAL OF THORACIC ONCOLOGY , no.9.
@article{article, author={B. Uluata Dayanc Et Al. }, title={Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2022}